A fter coronary thrombosis, the quantity of heart muscle that becomes necrotic (i.e., myocardial infarct size [MIS]) is an important (9), and microvasculature injury (7,10). Propranolol exerted an even more robust reduction of MIS when it was begun early rather than late after coronary occlusion (7).
A fter coronary thrombosis, the quantity of heart muscle that becomes necrotic (i.e., Animal models showed that when administered either before or during coronary artery occlusion, betablockers reduced epicardial ST-segment elevation and preserved myocardial creatine kinase concentration (5), intramural partial pressure of carbon dioxide (8) , structural damage of mitochondria (9) , and microvasculature injury (7, 10) . Propranolol exerted an even more robust reduction of MIS when it was begun early rather than late after coronary occlusion (7) .
Subsequently, we demonstrated that 2 IV betablockers, timolol (11) and the ultra-short-acting esmolol (12) , administered after the occlusion but before reperfusion reduced MIS in experimental models. These salutary effects were not observed in the presence of permanent coronary artery occlusion (i.e., in the absence of reperfusion) (13) .
Clinical trials before the use of fibrinolytic therapy to induce reperfusion provided mixed results regarding the ability of IV beta-blockers to reduce MIS. Some studies were encouraging (14, 15) , but others showed no effect (16) relevant to the contents of this paper to disclose. showing that MIS reduction is more robust when betablocker therapy is present during the entire period of ischemia rather than when it is administered late (7).
Therefore, consideration should be given to starting IV beta-blockade as early as possible in the course of STEMI. This could be in the ambulance, if possible, as was done by Mateos et al. (25) in a subgroup of patients in the METOCARD-CINC trial, or as soon as the patient presents to the emergency department, rather than after coronary anatomy has been defined just before reperfusion.
The finding that the longer that beta-blockade is "onboard" during the period of ischemia, the more myocardium is salvaged parallels animal data demonstrating that hypothermia, another intervention that protects ischemic myocardium by reducing myocardial oxygen needs, must be present during ischemia to reduce MIS (26, 27) ; the longer it is present during ischemia, the smaller the infarct (28) . However, the exact timing of early IV beta-blocker use in relation to coronary occlusion and reperfusion remains controversial, because a recent study with the short-acting beta-blocker esmolol found that a 24-h infusion begun immediately after the patient was transferred from the catheterization laboratory
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